0
0
Back to reports

Pharmaceuticals

GlobalData’s reports offer expert analysis, insights and opinions to companies in the world’s largest industries. Explore unique market-leading data today and benefit from access to actionable insight within the Pharmaceuticals market. Reports cover market growth forecasts, trends and research, and more.

Browse our full list of Pharmaceuticals market reports here.

Pharma
Industry
Geography
Report Type
Themes
Price
Publication date
Published Date
  • Company Insights

    $1,495 | May 2023
    Company Insights

    Novartis AG – Digital Transformation Strategies

    Novartis AG Digital Transformation Strategies Report Overview Novartis has been focusing on AI and data analytics technologies as a part of its digital transformation strategies. The annual ICT spending of Novartis was estimated at $2.2 billion in 2022. A major share of this spending is earmarked for acquiring network and communications, ICT services, and hardware from vendors. Novartis is a pharmaceutical company engaged in discovery, development, manufacturing, and marketing of prescription and generic pharmaceutical products. Total ICT Spending 2022 $2.2...

  • Thematic Analysis

    $995 | April 2023
    Thematic Analysis

    Brexit and the Healthcare Industry – Thematic Intelligence

    Brexit and the Healthcare Industry Thematic Report Overview It has been three years since the UK departed from the EU. Even though Brexit was feared to impact UK’s economic growth at that time, Great Britain had to simultaneously deal with additional challenges such as the COVID-19 pandemic, inflation, and the Russia-Ukraine war. While some believed that leaving the EU would bring opportunities for the UK and its healthcare sector, Brexit was also blamed for uncertainty, workforce shortages, and worsened economic performance....

  • Company Insights

    $1,495 | April 2023
    Company Insights

    Pfizer Inc – Digital Transformation Strategies

    Pfizer Inc Digital Transformation Strategies Overview Pfizer uses AI and data analytics to accelerate drug discovery and enhance operational efficiencies as a part of its digital transformation strategies. The annual ICT spending of Pfizer was estimated at $3.6 billion in 2022. A major share of this spending is earmarked for acquiring software, ICT services, and hardware from vendors. Pfizer Inc (Pfizer) discovers, develops, manufactures, and commercializes biopharmaceuticals. The company offers products to treat various conditions such as cardiovascular, metabolic and...

  • Sector Analysis

    $3,495 | April 2023
    Sector Analysis

    Allergic Conjunctivitis (AC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

    Allergic Conjunctivitis (AC) Marketed and Pipeline Drugs Report Overview Allergic conjunctivitis (AC) is an inflammatory response of the conjunctiva to an allergen or irritant such as pollen, dust, and mold. It is part of a larger systemic atopic reaction and is usually seasonal, with associated upper respiratory tract symptoms and complaints of redness and swelling of the conjunctiva, with severe itching and increased lacrimation. It has been estimated that that the highest diagnosed prevalence of AC will be in China,...

  • Sector Analysis

    $3,495 | April 2023
    Sector Analysis

    Idiopathic Pulmonary Fibrosis (IPF) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

    Idiopathic Pulmonary Fibrosis (IPF) Marketed and Pipeline Drugs Market Report Overview IPF is the most common subtype of idiopathic interstitial pneumonias (IIPs), which belong to a group of rare diseases termed interstitial lung diseases (ILDs). ILDs are characterized by damage to the lung parenchyma (the functional part of the lung that includes the alveolar tissue, bronchioles, bronchi, blood vessels, and interstitium) that occurs as a consequence of aberrant inflammation and fibrosis, thickening and scarring of the connective tissue. The development...

  • Company Profile

    $295 | April 2023
    Company Profile

    UroGen Pharma Ltd – Company Profile

    UroGen Pharma Ltd (UroGen Pharma), formerly TheraCoat Ltd, is a biopharmaceutical company that develops novel medicines to treat cancer indications and urologic diseases. The company products include Jelmyto is a drug formulation of mitomycin used to treat low-grade upper tract urothelial cancer. Its pipeline products include UGN-102 is a mitomycin gel is used to treat low-grade intermediate risk non-muscle invasive bladder cancer, UGN-201 and UGN-302 targets high-grade non-muscle invasive bladder cancer and Botox or RTgel for the treatment of overactive...

    Add to Basket
  • Company Profile

    $295 | April 2023
    Company Profile

    Xeris Biopharma Holdings Inc – Company Profile

    Xeris Biopharma Holdings Inc (XERIS) is the specialty pharmaceutical company that develops novel technology platforms to develop and commercialize stable injectable and infusible drug formulations. The company’s XeriSol formulation technology enables the subcutaneous and intramuscular delivery of concentrated formulations of proteins, peptides, antibodies and small molecules using syringes, multi-dose pens, auto-injectors and pumps. XERIS’s products are used in therapeutic areas such as severe hypoglycemia, post-bariatric hypoglycemia, congenital hyperinsulinism, hypoglycemia-associated autonomic failure, exercise-induced hypoglycemia, acute repetitive seizures and type 1/type 2...

    Add to Basket
  • Company Profile

    $295 | April 2023
    Company Profile

    Curevac NV – Company Profile

    Curevac NV (Curevac) is a clinical-stage biopharmaceutical company that develops RNA-based medicines. The company develops, designs, and produces messenger rna molecules for therapeutic and prophylactic vaccines in the fields of oncology and infectious diseases. Its product pipeline includes Cv0501, Cv2cov, Flu Sv Mrna and Cvsqiv. Curevac mrna-based prophylactic vaccines candidates comprise cv7202 and cv8102. it also carries out the research and development. The company Cv8102, a lead oncology candidate is designed to modulate the tumor microenvironment. Its products are used...

    Add to Basket
  • Company Profile

    $295 | April 2023
    Company Profile

    Precigen Inc – Company Profile

    Precigen Inc (Precigen), formerly Intrexon Corp, is a clinical stage biotechnology company that develops synthetic biology solutions. It offers clinical and pre clinical products. The company clinical products include PRGN-3006, PRGN-3005, AG019, PRGN-2009, PRGN-2012 and PRGN-3007. The company's pre clinical product portfolio comprises of PRGN-3008, PRGN-5001,PRGN-2010, PRGN-2011, PRGN-5002, PRGN-2013, AG017, PRGN-3009 and PRGN-3010. Precigen provides treatment in areas of immuno-oncology, autoimmune disorders, infectious diseases, solid tumors, celiac disease, heart failure, ovarian cancer and type 1 diabetes. It therapeutics platforms include...

    Add to Basket
  • Company Profile

    $295 | April 2023
    Company Profile

    Jounce Therapeutics Inc – Company Profile

    Jounce Therapeutics Inc (Jounce Therapeutics) is a clinical stage immunotherapy company. It develops therapies that enable the immune system to attack tumors. The company’s major pipeline products include Vopratelimab, an IgG1 monoclonal antibody that activates T cells through ICOS, JTX-8064, an LILRB2 inhibitor novel antibody, JTX-1484, target is LILRB4, pimivalimab target receptor is PD-1, GS-1811, target receptor is CCR8. Its discovery programs include LILRB1, treatment of myeloid and lymphoid cancers. Jounce offers services in the areas of tumor immunology, antibody...

    Add to Basket
  • Company Profile

    $295 | April 2023
    Company Profile

    Forma Therapeutics Inc – Company Profile

    Forma Therapeutics Inc (Forma) a subsidiary of Novo Nordisk AS, is a biotech company. It develops technologies to identify the initial molecules that provide drug discovery program. It offers research in the areas of tumor metabolism, protein homeostasis, epigenetics, and protein-protein interactions. FORMA’s drug development process includes computational and medicinal chemistry, parallel synthesis, X-ray crystallography, and relevant biology studies. The company collaborates with biotechnology companies, pharmaceuticals and biomedicine companies and research institutes for its research and development activities. It operates...

    Add to Basket
  • Company Profile

    $295 | April 2023
    Company Profile

    IVERIC bio Inc – Company Profile

    IVERIC bio Inc (IVERIC bio), formerly known as Ophthotech Corp, is a biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases with a focus on age-related and orphan retinal diseases. The company’s products include Zimura, a complement inhibitor for stargardt disease. It provides Fovista, an anti-platelet-derived growth factor (PDGF). IVERIC bio offers gene therapy research programs, dry age-related macular degeneration and ophthalmic orphan programs. The company seeks to collaborate with companies and academic institutions to develop gene therapy product...

    Add to Basket
  • Company Profile

    $295 | April 2023
    Company Profile

    Vaxcyte Inc – Company Profile

    Vaxcyte Inc (Vaxcyte), formerly SutroVax Inc, is a clinical-stage vaccine innovation company. It develops novel vaccines to prevent and treat infectious diseases. The company does research on VAX-24, an invasive pneumococcal disease (IPD), VAX-XP, a superior conjugate vaccine against IPD, VAX-A1, group A strep infections in children, and VAX-PG, a novel protein vaccine, targeting periodontitis in adults. It utilizes a cell-free protein synthesis platform to design and produce protein carriers and antigens, the critical building blocks of vaccines. The company...

    Add to Basket
  • Company Profile

    $295 | April 2023
    Company Profile

    Avidity Biosciences Inc – Company Profile

    Avidity Biosciences Inc (Avidity Biosciences), formerly Avidity NanoMedicines LLC is a biotech company that develops antibody oligonucleotide conjugates (AOCs). Its proprietary platform technology has enhanced pharmacokinetic and biodistribution properties that improve the delivery of multiple therapeutic oligonucleotides. Its pipeline of therapeutic programs is intended for the treatment of rare muscle disorders and other serious diseases, including Duchenne muscular dystrophy, myotonic dystrophy and muscle atrophy. The company has research collaborations with leading pharma companies, to discover antibody-based drug candidates against various...

    Add to Basket
  • Company Profile

    $295 | April 2023
    Company Profile

    Intellia Therapeutics Inc – Company Profile

    Intellia Therapeutics Inc (Intellia Therapeutics) is a biotechnology company. The company developing curative therapeutics using Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) technology. It develops in vivo programs for the treatment of liver diseases such as alpha-1 antitrypsin deficiency, and primary hyperoxaluria Type 1. Intellia Therapeutics also develops ex vivo programs such as hematopoietic stem cells (HSCs) and chimeric antigen receptor T cells (CAR-T cells). The company’s pipeline products include OTQ923 / HIX763, NTLA-5001. The company conducts genome...

    Add to Basket
  • Company Profile

    $295 | April 2023
    Company Profile

    Biora Therapeutics Inc – Company Profile

    Biora Therapeutics Inc (Biora Therapeutics), formerly Progenity Inc, is a biotechnology company. It develops oral biotherapeutics to replace injection with needle-free. The company's pipeline products portfolio includes PGN-600 and PGN-001 liquid formulations delivered with the drug delivery system for the treatment of ulcerative colitis, PGN-OB1 liquid formulation of anti-TNF-alpha monoclonal antibody delivered with the oral biotherapeutics delivery system for the treatment of autoimmune conditions, and PGN-OB2 liquid formulation. It develops smart capsule platforms recoverable sampling systems and PIL Dx for...

    Add to Basket
  • Company Profile

    $295 | April 2023
    Company Profile

    Athenex Inc – Company Profile

    Athenex Inc (Athenex), formerly known as Kinex Pharmaceuticals Inc, is a biopharmaceutical company focused on the discovery, development of autologous and allogeneic CAR-NKT cell therapies to treat cancers. The company's product pipeline includes KUR-501–GD2, KUR-502–CD19, KUR-503–GPC3 and p53-KRAS and EGFR. Athenex platform includes oncology innovation Platform for research and development, commercial platform for manufacturing and marketing of products and global supply chain which provide APIS to clinical and commercial effort. The company partners with pharmaceutical companies, universities and research institutions...

    Add to Basket
  • Company Profile

    $295 | April 2023
    Company Profile

    EyePoint Pharmaceuticals Inc – Company Profile

    EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a pharmaceutical company that develops and commercializes therapies for treatment of eye disorders. The company utilizes its Duraset platform, a miniaturized, injectable, and sustained delivery system to develop its product. Its pipeline products includes EYP-1901, an investigational sustained delivery intravital anti-VEGF treatment that targets wet age-related macular degeneration (Wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macularedema (DME). The company also markets its product such as Yutiq, a fluocinolone acetonide intravitreal implant...

    Add to Basket
  • Company Profile

    $295 | April 2023
    Company Profile

    Applied Genetic Technologies Corp – Company Profile

    Applied Genetic Technologies Corp (AGTC) is a pharmaceutical company. The company Invovled in development of eye disease cures. AGTC develops treatments for patients that have diseases caused by broken genes. It offers products such X-linked retinitis pigmentosa, achromatopsia, bionic sight, age-related macular degeneration ,non-syndromic hearing loss and deafness ,frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company’s achromatopsia provides treatment for inherited conditions that are associated with visual acuity loss, extreme light sensitivity resulting in daytime blindness, and total...

    Add to Basket
  • Company Profile

    $295 | April 2023
    Company Profile

    AbCellera Biologics Inc – Company Profile

    AbCellera Biologics Inc (AbCellera) is a biotechnology company that discovers and develops next-generation therapeutic antibodies. The company’s single-cell platform helps in discovering rare antibodies by combining proprietary immunizations, microfluidics, high-throughput imaging, genomics, deep computation, artificial intelligence and laboratory automation technology. AbCellera ultra-deep screening of single B cells allows access to immune responses which enables isolation of large and diverse panels of high antibodies from any species. The company works in partnership with Pfizer, Merck, GSK, Teva Pharmaceutical, Kodiak Sciences, Denali...

    Add to Basket

Testimonial

Your Drugs database is great, you can find all the information you want such as sales forecasts, countries, diseases, dates, clinical trials, and patent expiration. We are using this information to research the leading competitive products in our current project. In addition, we analyze the profiles of the leading products and use this information to set the differentiation profile of our own products and clarify our positioning. In terms of business forecasts, we are able to provide more objective figures by using the Drug Forecast and Market Analysis report series. The analysis of product share by disease (series of Drug Forecast and Market Analysis reports) is used for business feasibility assessment.”

The ability to evaluate or provide information on PJs in R&D from both product and disease perspectives (it is difficult to find a database that can be used comprehensively for both), stands GlobalData out from other providers. The release of new functions such as Likelihood of approval (LoA) analysis, which was something I wanted but did not exist, shows that GlobalData have done a good job of researching the industry and developing services from the customer’s perspective which is another positive.

GlobalData’s COVID-19 Bulletin, which is sent out several times a week, provides the latest information on COVID-19 related vaccines and therapeutics and is used as background information.

Business Development, Meiji Seika Pharma

GlobalData provides extensive and comprehensive Pharma and Biotech data along with spectacular customer support. I use their drug, trial and company data on a daily basis to support our sales and marketing efforts.”

, PPD

“As a global biopharma R&D strategy consultancy, we use the GlobalData Pharma Intelligence platform across a broad spectrum of topics, it provides all key data in one place

, Scitaris
Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.